Compare CNK & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNK | GRFS |
|---|---|---|
| Founded | 1984 | 1940 |
| Country | United States | Spain |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 5.2B |
| IPO Year | 2007 | 2008 |
| Metric | CNK | GRFS |
|---|---|---|
| Price | $37.04 | $8.05 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 2 |
| Target Price | ★ $33.70 | $10.15 |
| AVG Volume (30 Days) | ★ 2.5M | 529.1K |
| Earning Date | 05-01-2026 | 07-28-2022 |
| Dividend Yield | 1.24% | ★ 1.80% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,115,000,000.00 | N/A |
| Revenue This Year | $11.01 | $4.49 |
| Revenue Next Year | $3.70 | $6.42 |
| P/E Ratio | ★ N/A | $18.67 |
| Revenue Growth | ★ 2.15 | N/A |
| 52 Week Low | $21.60 | $6.96 |
| 52 Week High | $38.98 | $10.23 |
| Indicator | CNK | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 61.01 | 56.17 |
| Support Level | $36.28 | $7.87 |
| Resistance Level | $38.98 | $8.36 |
| Average True Range (ATR) | 0.97 | 0.18 |
| MACD | -0.24 | -0.00 |
| Stochastic Oscillator | 36.10 | 54.29 |
Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres. Cinemark manages its business under two reportable segments: U.S. markets and international markets. The majority of its revenue is generated from the U.S. markets segment.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.